Full name
SALUBRIS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.21.Z - General medical practice
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
72 - Scientific research and development activities
85 - Education
86.22.Z - Specialist medical practice
86.23.Z - Dental practice
86.90 - Other healthcare activities
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,4 | -0,1 | 0,2 | 372,7 |
Gross profit (loss) | 0,4 | -0,1 | 0,2 | 371,2 |
EBITDA | 0,5 | -0 | 0,4 | 3866,9 |
Short time liabilities | 0,2 | 0,2 | 0,1 | -28,2 |
Other operating costs | 0 | 0 | 0,1 | 790,1 |
Equity capital | 1 | 0,8 | 1 | 13 |
Operating profit (EBIT) | 0,4 | -0,1 | 0,2 | 380,1 |
Assets | 1,2 | 1 | 1,1 | 6,5 |
Net profit (loss) | 0,3 | -0,1 | 0,2 | 342,3 |
Cash | 0,3 | 0,3 | 0,3 | 29,2 |
Net income from sale | 3,3 | 3 | 3,2 | 6,9 |
Liabilities and provisions for liabilities | 0,2 | 0,2 | 0,1 | -28,2 |
Working assets | 0,6 | 0,7 | 0,8 | 14,4 |
Other income costs | 0 | 0 | 0,1 | 699,7 |
Depreciation | 0,1 | 0,1 | 0,1 | 44,5 |
% | % | % | p.p. | |
Profitability of capital | 33,1 | -10,5 | 22,6 | 33,1 |
Equity capital to total assets | 82,9 | 84,2 | 89,3 | 5,1 |
Gross profit margin | 11,3 | -3 | 7,5 | 10,5 |
EBITDA Margin | 14,2 | -0,3 | 11,2 | 11,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 23 | 19 | 13 | -6 |
Current financial liquidity indicator | 2.7495172023773193 | 4.318459510803223 | 6.875413417816162 | 2,6 |
Net dept to EBITDA | -0.6022513508796692 | 24.860904693603516 | -0.9146150350570679 | -25,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane